REACH Personal Mobility Device Testing (REACH)
Musculoskeletal Diseases or Conditions, Rehabilitation
About this trial
This is an interventional treatment trial for Musculoskeletal Diseases or Conditions
Eligibility Criteria
Inclusion Criteria:
- seniors (65+) hospitalized in one of the involved sites at the Geneva University Hospital, with musculoskeletal issues (fracture, prosthesis, falls and low back pain), a minimal level of independence and strength (FIM >= 4 for the items regarding mobility and locomotion), and minimal level of cognitive ability (MMSE>=24); be able to interact with the equipment and be hospitalized at least 3 weeks at one of the hospitals.
Exclusion Criteria:
- patients that are considered too weak to interact with the device and that are hospitalized less than three weeks.
Sites / Locations
- Geneva University Hospitals
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention REACH group
Control group (Standard of care)
The intervention REACH consists of a mobility device called ActivLife developed by Alreh Medical, that is coupled with serious games, a Kinect sensor and a wearable sensor called Stepwatch, to continuously measure the patients physical activity. The participants will receive 30 min training every day during 3 weeks. 3 times a week the standard training will be replaced with the intervention. The training is conducted/ supervised by a physiotherapist.
The participants will receive the standard of care as intervention which consists of 30 min training every day during 3 weeks. The training is conducted by a physiotherapist.